Tong Ren Tang 1H net income 945.5M yuan

Tong Ren Tang 1H net income 945.5M yuan

Shenzhen, China - July 2, 2025 - Tong Ren Tang, a leading Chinese herbal medicine company, has announced its first-half (1H) 2025 net income, which stands at 945.5 million yuan (approximately 140.8 million USD). The company has been steadily expanding its product portfolio and distribution channels, contributing to its robust financial performance.

Tong Ren Tang specializes in the production and sale of Chinese herbal medicines, chemical medicines, and health food products. The company operates through various channels, including medical institutions, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, and mobile medical care. Founded in 1997 and based in Shenzhen, Tong Ren Tang has been instrumental in the growth of the Chinese pharmaceutical sector.

The company's strong first-half performance is a reflection of its diversified product offerings and strategic distribution network. Tong Ren Tang's ability to cater to both traditional and modern healthcare needs has positioned it as a key player in the market. The company's commitment to innovation and quality has also been a significant factor in its success.

As Tong Ren Tang continues to expand its market reach and product offerings, investors and financial professionals are closely monitoring the company's performance. The 1H net income of 945.5 million yuan indicates a positive trend and suggests that Tong Ren Tang is well-positioned for future growth.

For more information about Tong Ren Tang, visit www.kangmei.com.cn.

References:
[1] https://finance.yahoo.com/quote/600518.SS/